8 results on '"Refici, Marion"'
Search Results
2. Abstract 5339: BCL2A1 is expressed in myelofibrosis specimens and JAK2-mutated UKE-1 cells, yet does not inhibit synergistic cell killing by BCL-XL inhibitor navitoclax plus JAK1/2 inhibitors, including ruxolitinib
3. The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
4. Fc[Gamma]-receptor signaling augments the LPS-stimulated increase in serum tumor necrosis factor-[Alpha] levels
5. ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo
6. Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models
7. Antitumor Activity of Orally Bioavailable Farnesyltransferase Inhibitor, ABT-100, Is Mediated by Antiproliferative, Proapoptotic, and Antiangiogenic Effects in Xenograft Models
8. Fcγ-receptor signaling augments the LPS-stimulated increase in serum tumor necrosis factor-α levels
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.